The subject matter of the present invention is directed to novel substituted beta-carbolines, and specifically compounds of the formula I,
1
which are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of I&kgr;B kinase is involved.
本发明涉及新型取代的β-
咔唑啉,具体而言是公式I,1的化合物,适用于生产用于预防和治疗其过程中涉及IκB激酶活性增加的疾病的药物。